Login / Signup

Financial analysis of large-volume delayed sampling to reduce bacterial contamination of platelets.

Seema KackerLouis M KatzPaul M NessEvan M BlochRuchika GoelEric Abraham GehrieParvez M LokhandwalaAaron A R Tobian
Published in: Transfusion (2020)
LVDS is an effective and cost-competitive approach, assuming additional costs to blood centers and associated charges to hospitals are modest.
Keyphrases
  • risk assessment
  • drinking water
  • healthcare
  • health risk
  • human health
  • red blood cell
  • affordable care act
  • heavy metals
  • climate change